Form 4 for OM Outset Medical, Inc.
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-11 · accession 0001484612-22-000070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-14 | 2022-11-11 | OM | Trigg Leslie | COB, CEO, Dir | M - OptEx | $3.88 | +30.0K | 321.2K | +10% | +$116.4K |
| D | 2022-11-14 | 2022-11-11 | OM | Trigg Leslie | COB, CEO, Dir | S - Sale+OE | $20.00 | -30.0K | 291.2K | -9% | -$600.0K |
| D | 2022-11-14 | 2022-11-11 | OM | Trigg Leslie | COB, CEO, Dir | M - OptEx | $0.00 | -30.0K | 130.5K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | M | A | 30,000 | $3.88 | 321,159 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-11 | S | D | 30,000 | $20.00 | 291,159 | D | — | — | |
| 3 | Derivative | Performance Options (right to buy) | 2022-11-11 | M | D | 30,000 | $0.00 | 130,508 | D | $3.88 · — to 2027-09-19 | 30,000 Common Stock | (F2) In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. |